SoVote

Decentralized Democracy

House Bill

Bill C-10

44th Parl. 1st Sess.
March 04, 2022
An Act respecting certain measures related to COVID-19
  • Bill C-10, also known as the An Act respecting certain measures related to COVID-19, allows the Minister of Health to use up to $2.5 billion from the government's funds to pay for COVID-19 tests. It also gives the Minister the authority to transfer COVID-19 tests and instruments to provinces, territories, and other organizations in Canada. The bill was passed on March 4, 2022, and more information can be found on the House of Commons website.
  • H1
  • H2
  • H3
  • S1
  • S2
  • S3
  • RA
  • Yea (344)
  • Nay (51)
  • star_border

SteelmanSpren in Favour

  • One steelman argument in favor of this act is that it provides necessary funding and resources for COVID-19 testing. The $2.5 billion allocation from the Consolidated Revenue Fund allows the Minister of Health to address the growing demand for tests and ensure that individuals can easily access them. By transferring tests and instruments to provinces, territories, and other entities in Canada, the act supports a coordinated and efficient approach to testing. This can help identify and control the spread of COVID-19, protect public health, and ensure timely treatment for those affected. The act demonstrates the government's commitment to addressing the ongoing pandemic and prioritizing the health and well-being of Canadians.

SteelmanSpren Against

  • Steelman Argument Opposing the Act: The Act authorizing the Minister of Health to make payments and transfer COVID-19 tests and instruments raises several concerns. Firstly, the allocation of $2.5 billion from the Consolidated Revenue Fund for COVID-19 tests may not be the most effective use of public funds. Prioritizing funding for tests could divert resources from other critical areas such as vaccine distribution, healthcare infrastructure, and support for businesses and individuals affected by the pandemic. Secondly, the Act does not provide clear guidelines or criteria for the distribution of tests and instruments to provinces, territories, and other bodies or persons in Canada. This lack of transparency may lead to unequal distribution, favoritism, and possible misuse of resources. Furthermore, the Act grants broad powers to the Minister of Health without sufficient oversight mechanisms. This concentration of power raises concer
Senate Third Reading
  • March 4, 2022, 10 a.m.
  • Passed
Royal Assent
  • March 4, 2022, 10 a.m.
  • Read